Binding Affinity

Binding Affinity describes the strength of interaction between two molecules, such as a therapeutic antibody and its antigen, a receptor and ligand, or an enzyme and substrate. This fundamental parameter influences biological activity, target engagement, and therapeutic potency, often quantified through equilibrium dissociation constants and kinetic measurements. High binding affinity can improve efficacy by enhancing target occupancy, though overly strong binding may influence tissue distribution, clearance, or safety profiles.

In biopharmaceutical development, binding affinity assessment guides candidate selection, engineering decisions, and comparability studies throughout the product lifecycle. Companies use technologies including surface plasmon resonance and biolayer interferometry to measure binding kinetics and affinity constants under controlled conditions. For monoclonal antibodies and other targeted biologics, binding affinity data supports mechanism of action understanding and informs dose selection strategies in clinical trials. Regulatory submissions frequently include binding affinity characterisation as part of demonstrating product identity, potency, and functional consistency across manufacturing changes and commercial batches.